Showing 621-630 of 3255 results for "".
New Biologics
https://practicaldermatology.com/topics/psoriasis/new-biologics/18635/Craig Leonardi, MD, shares insight on developments in biologics that may offer significantly improved efficacy compared with existing agents. Dr. Leonardi also discusses the rapidly evolving treatment paradigm in the management of psoriasis.The Horizon of Aesthetic Treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-horizon-of-aesthetic-treatments/19036/Dina Anderson, MD, FAAD, takes a look at the future of aesthetic procedures, particularly treatments for submental fat as well as the ocular area that may play a major role in shaping the spectrum of aesthetic procedures.Science of Skincare Summit 2024:The Latest in Exosomes
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-the-latest-in-exosomes/29450/Practical Dermatology talks with Todd Schlesinger, MD, a dermatologist and Mohs surgeon, and a member of the Editorial Board, about the latest updates in exosomes and what to expect next. This video was recorded at the Science of Skincare Summit in Austin.ISDPA: Dr. Dy on JAK Inhibitors for Alopecia Areata
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-dy-jak-inhibitors-alopecia-areata/29150/Lady Dy, MD, talks about the efficacy and safety of JAK inhibitors for treating alopecia areata at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Gaps in Treatment and Approaches for the Pediatric Population with Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37160/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, describes gaps in treatment for children with atopic dermatitis and reasons for optimism based on ongoing clinical trials.Clinical Predictors for Distinguishing Transient Pediatric Atopic Dermatitis from Early-onset Atopic March Cases
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37159/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, talks about clinical predictors for atopic dermatitis vs early-onset atopic march.Clinical Data on Switching to Upadacitinib
https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.The Latest in Blistering Diseases
https://reachmd.com/programs/practical-dermatology/the-latest-in-blistering-diseases/33007/Kim B. Yancey, MD, a professor of dermatology at UT Southwestern Medical Center in Dallas, talks about current treatments and techniques for blistering diseases, focusing specifically autoimmune blistering diseases.Updates in Cutaneous Lupus
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-cutaneous-lupus/33008/Joseph Merola, MD, a dermatologist, rheumatologist, Chair and professor of dermatology at UT Southwestern Medical Center in Dallas, outlines his talks at Masterclasses in Dermatology talking about emerging therapies in cutaneous lupus.SDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.